Mind Medicine Inc (NAS:MNMD)
$ 8.19 -0.78 (-8.7%) Market Cap: 600.59 Mil Enterprise Value: 438.17 Mil PE Ratio: 0 PB Ratio: 2.93 GF Score: 41/100

Mind Medicine (MindMed) Inc at Cowen Health Care Conference Transcript

Mar 08, 2023 / 06:30PM GMT
Release Date Price: $3.34
Rob Barrow;MindMed;Inc.;CEO
Mind Medicine

()-

All right. Terrific. Well, thank you all for being here and taking the time to listen and learn more about Mind Medicine, MindMed.

Before we start, [as always], we are a publicly traded company listed on Nasdaq. And I always give the disclaimer that we are providing forward-looking statements and obviously all the legal disclosure and disclaimers that come along with that.

Starting off our orientation, I'm Rob Barrow. I'm the CEO of MindMed. I've had the good fortune of working here for the last two years. First as the head of R&D and then as the CEO starting June of 2021. Really we've -- believe we've built one of the most nimble, effective teams in the entire industry.

Prior to joining MindMed, I was the head of R&D for an organization developing silicide, similar therapeutic area, and ultimately was able to obtain a breakthrough therapy designation for that program. And have brought to MindMed and built the team at MindMed aligned around really a highly convicted approach

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot